Roberto Hofmann, PhD, Senior Analyst, will speak at Biotech for Good 2026: Innovation, Investment and Resilience, taking place on Monday 16 November at Incyte’s offices.
The event brings together biotechnology’s builders and investors for an evening of forward-looking perspectives, engaging conversations and meaningful connections. Attendees will explore the future of biotech innovation and investment while considering the resilience required to build and support the next generation of life sciences companies.
Biotech for Good proudly supports the Blue Dragon Children’s Foundation, which works to rescue and protect children from human trafficking and exploitation while providing education, shelter and long-term support. The event combines industry collaboration with the opportunity to contribute to Blue Dragon’s life-changing mission.